Sagent Pharmaceuticals announces acquisition of Raleigh manufacturing site

02:51 EST 4 Mar 2019 | Pharmaceutical Business Review

Financial terms of the transaction have not been disclosed. The manufacturing site, which is approved for manufacturing of both small molecule and biologic products, is the first FDA-approved

The post Sagent Pharmaceuticals announces acquisition of Raleigh manufacturing site appeared first on Pharmaceutical Business review.

More From BioPortfolio on "Sagent Pharmaceuticals announces acquisition of Raleigh manufacturing site"